Supporters of kratom use urge president to end regulatory proceeding | Addiction Professional Magazine Skip to content Skip to navigation

Supporters of kratom use urge president to end regulatory proceeding

March 3, 2017
by Gary A. Enos, Editor
| Reprints

Having organized a public comment response that was overwhelmingly opposed to a proposed Schedule I listing for kratom, the consumer-based American Kratom Association has followed up with an online petition to President Trump.

More than 26,000 individuals have signed on to the petition to the president, which states in part, “Your promise to end excessive government regulations and restore the limited role of government in the lives of Americans is the reason that we are appealing to you today.”

After announcing last summer that it planned to schedule the plant and its derivative products as a Schedule I drug in an emergency action, the Drug Enforcement Administration (DEA) halted that move and initiated a public comment period after widespread protest. Members of the research community say more investigation of kratom is necessary because some of its alkaloids appear to have strong potential as an analgesic.

The American Kratom Association, whose director was a longtime worker in the environmental field who uses kratom to relieve symptoms of Lyme disease, reports that over 99% of the more than 23,000 public comments that came in were opposed to a Schedule I designation. The association says a website it created to facilitate the commenting process generated more than 16,000 of those comments.

The petition asks the president to end the DEA's regulatory proceeding, stating, “The DEA and the U.S. Food and Drug Administration have openly declared war on kratom consumers, and these agencies are blatantly abusing their powers to criminalize both those who produce and sell kratom products, and those who purchase and consume them.”